Historical review from 2026-11-16. Current price and availability are unconfirmed; check the original marketplace.
Hydrofy shows attractive unit economics: $203/mo profit at 85% margin on a 2.0x multiple is well below market for recurring apps. However, the very low monthly revenue ($238/mo) and absence of critical traction data—customer count, retention, organic growth rate, and acquisition channels—create material uncertainty about business durability and growth. Verification flag is positive, but buyer should request detailed historical data and churn metrics to assess whether this is a stable niche product or an early-stage experiment.
While the software is lightweight and could be reproduced in 10 weeks with AI-assisted development ($3,500–$8,500 all-in), the core value being acquired is minimal traction: only $238/mo revenue with no evidence of customer base size, retention, repeat usage, or organic distribution channels. The absence of verified paying-customer count, churn data, and growth history means the buyer cannot differentiate between a stable niche product and an early-stage experiment. Without proof of business durability or customer acquisition economics, the acquisition premium does not offset the risk of building a comparable app and growing organically in the same niche. A buyer should build independently and validate market fit in parallel rather than acquire unproven traction at any price.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Hydrofy helps home hydroponic growers plan gardens, log pH and nutrient readings, track plants from seed to harvest, and spot problems with AI-assisted diagnosis on iPhone and iPad.
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.